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Introduction
Harmful exposures in utero are thought to contribute to the de-
velopment of chronic disease later in life, including asthma.1–3 
Maternal tobacco smoking during pregnancy is one of these expo-
sures, with children exposed while in utero being at greater risk 
of adverse health effects,4–7 including asthma.8–10 Among children 
with asthma, those with in utero tobacco smoke exposures have 
been shown to have more severe and difficult to control asthma,11 
while in utero tobacco smoke exposure is also adversely related to 
fetal lung growth12–14 and lung function in childhood.8,14–17
There is mounting evidence that exposures such as maternal 
smoking during pregnancy can have epigenetic effects on DNA 
methylation measured at birth,18,19 childhood,18 and adult-
hood,20 suggesting potentially persisting effects on DNA methyl-
ation. DNA methylation is well known to alter gene expression 
and may be one of the pathways by which in utero tobacco 
smoke exposures exert health effects, with recent studies sug-
gesting that the effects of maternal smoking during pregnancy 
on birth weight may be mediated through DNA methylation.21,22 
Fetal lung and placental methylation has also been linked to to-
bacco smoke exposure during pregnancy, suggesting that DNA 
aDivision of Environmental Health Sciences, School of Public Health, University 
of California, Berkeley, California; bDepartment of Environmental and Radiological 
Health Sciences, Colorado State University, Fort Collins, Colorado; cDepartment 
of Medicine, University of California, San Francisco, California; dCentro de 
Neumología Pediátrica, San Juan, Puerto Rico; eDivision of Allergy and 
Immunology, Feinberg School of Medicine, Northwestern University, Chicago, 
Illinois; and fAnn & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois.
Sponsorships or competing interests that may be relevant to content are 
disclosed at the end of the article.
This study was supported by Sandler Family Foundation, the American 
Asthma Foundation, the RWJF Amos Medical Faculty Development Program, 
Harry W. and Diana V. Hind Distinguished Professor in Pharmaceutical 
Sciences II, National Institutes of Health R01HL117004, R01HL128439, 
R01HL135156, 1X01HL134589, R01HL141992, National Institute of Health and 
Environmental Health Sciences R01ES015794, R21ES24844, K99ES027511, 
the National Institute on Minority Health and Health Disparities P60MD006902 
RL5GM118984, R01MD010443 and the Tobacco-Related Disease Research 
Program under Award Number 24RT-0025, 27IR-0030.
Data Availability: GALA II methylation data are publicly available in the Gene 
Expression Omnibus (GEO) database (accession number GSE77716). For 
questions regarding code please contact the corresponding author.
  Supplemental digital content is available through direct URL citations in 
the HTML and PDF versions of this article (www.environepidem.com).
*Corresponding Author. Address: Department of Environmental and 
Radiological Health Sciences, Colorado State University, 1681 Campus Delivery, 
Fort Collins, CO 80523–1681, USA. E-mail: Andreas.Neophytou@colostate.edu 
(A. M. Neophytou). 
In utero tobacco smoke exposure, DNA 
methylation, and asthma in Latino children
Andreas M. Neophytoua,b*, Sam S. Ohc, Donglei Huc, Scott Huntsmanc, Celeste Engc,  
José R. Rodríguez-Santanad, Rajesh Kumare,f, John R. Balmesa,c, Ellen A. Eisena, Esteban G. Burchardc
Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on 
behalf of Environmental Epidemiology. All rights reserved. This is an open access 
article distributed under the Creative Commons Attribution License 4.0 (CCBY), 
which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Environmental Epidemiology (2019) 3:e048
Received: 3 December 2018; Accepted 26 March 2019
Published online 29 April  2019
DOI: 10.1097/EE9.0000000000000048
Background: Maternal smoking during pregnancy is a risk factor for chronic disease later in life and has been associated with 
variability of DNA methylation at specific cytosine-phosphate-guanine (CpG) loci. We assessed the role of DNA methylation as a 
potential mediator of adverse effects of in utero tobacco smoke exposures on asthma outcomes in Latino children from the US 
mainland and Puerto Rico.
Methods: Relationships between self-reported exposure and DNA methylation at CpG loci previously reported to be associated 
with maternal smoking were assessed in a subsample consisting of 572 children aged 8–21 years (310 cases with asthma, 262 
healthy controls), sampled from a larger asthma case-control study. Subsequently, we assessed associations between top loci and 
asthma-related outcomes, followed by mediation analysis for loci for which associations with outcomes were observed.
Results: Self-reported maternal smoking was associated with a −1.5% (95% confidence interval (CI) = −2.4%, −0.6%) lower meth-
ylation at CpG locus cg05575921 on the AHRR gene; a 1% increase in DNA methylation at the same locus resulted in an odds ratio 
(OR) of 0.90 (95% CI = 0.83, 0.96) for the odds of asthma. The OR for the indirect effect of maternal smoking on asthma mediated 
through methylation at the cg05575921 locus was 1.18 (95% CI = 1.07, 1.68), compared to the OR for the total effect of exposure 
in the parent study of 1.48 (95% CI = 1.03, 2.11).
Conclusions: Our findings suggest potential mediation by DNA methylation in the association between maternal smoking during 
pregnancy and asthma status.
What this study adds
In this study we assess the relationship between maternal smok-
ing during pregnancy and DNA methylation in minority children 
with asthma, as well as consider the role of DNA methylation 
as a potential mediator for effects of in utero tobacco smoke 
exposures on asthma. We quantify indirect effects of exposure on 
odds of asthma with respect to DNA methylation at an identified 
gene in the framework of mediation analysis. Our findings high-
light the potential role of DNA methylation as a mediator of the 
effects of in utero exposures on asthma and further underscore 
the importance of smoking prevention and cessation.
This is an open access article distributed 
under the Creative Commons Attribution 
License 4.0 (CCBY), which permits unre-
stricted use, distribution, and reproduction 
in any medium, provided the original work 
is properly cited.
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methylation may be an intermediate between smoke exposure 
and adverse effects on lung development.23
Maternal smoking during pregnancy remains an impor-
tant risk factor, with an estimated 12.3% of pregnant women 
smoking in United State, despite increased awareness of the as-
sociated risks in recent years.24 Minorities tend to have higher 
prevalence of exposure, with African American and Puerto 
Rican women more likely to smoke during pregnancy than 
Whites in the United States.11,24 Minority children are also dis-
proportionately affected by asthma, with asthma morbidity and 
mortality being highest among African Americans and Puerto 
Ricans but lowest in Mexicans.25,26 Recent studies report poten-
tial effect modification by maternal folate intake27 and normal-
ization of DNA methylation levels in pregnant smokers with 
Vitamin C treatment, with restoration of methylation at specific 
cytosine-phosphate-guanines (CpGs) that were also associated 
with phenotypic respiratory outcomes.28 This finding suggests 
that DNA methylation can be a potential intervention site for 
the effects of maternal smoking during pregnancy.29
In the present study, we examine the relationships between 
DNA methylation at specific CpG loci previously identified 
to be associated with in utero tobacco smoke exposures in a 
meta-analysis of older pediatric and adolescent cohorts,18 with 
(1) self-reported maternal smoking during pregnancy and with 
(2) asthma-related outcomes as well as lung function in a study 
of Latino children from the US mainland and Puerto Rico. We 
also perform mediation analysis for the effects of in utero to-
bacco smoke exposure on lung function as potentially mediated 
through DNA methylation loci, in an effort to quantify indirect 
effects of maternal smoking during pregnancy on asthma, which 
in theory could be eliminated by intervening on the mediator.
Methods
Study participants
This study is based on the Genes-environments and Admixture 
in Latino Americans (GALA II) study. GALA II is described in 
detail elsewhere.11 Briefly, GALA II is an asthma case–control 
study of 4,702 children (2,374 participants with asthma and 
2,328 healthy controls) recruited from five centers (Chicago, 
IL; Bronx, NY; Houston, TX; San Francisco Bay Area, CA; and 
Puerto Rico). Participants were 8–21 years old, self-identified as 
Latino and must have had four Latino grandparents. Exclusion 
criteria were 10 or more pack-years of smoking; any smoking 
within 1 year of recruitment date; history of lung diseases other 
than asthma (cases) or chronic illness (cases and controls); or 
pregnancy in the third trimester.
Exposure and methylation data
Data on self-reported maternal smoking during pregnancy 
were collected through questionnaires administered in-per-
son with the children’s parents/caretakers by trained bilingual 
(English–Spanish) interviewers at the time of study recruitment. 
Specifically, we asked if the child’s mother smoked while she 
was pregnant with the child (yes/no). Genomic DNA (gDNA) 
was extracted from whole blood, collected at the time of recruit-
ment using Wizard Genomic DNA Purification Kits (Promega, 
Fitchburg, WI). A subset of 572 participants (310 cases with 
asthma and 262 healthy controls) was measured for DNA meth-
ylation using the Infinium Human-Methylation450 BeadChip 
(Illumina, Inc., San Diego, CA) following the manufacturer’s 
instructions. Raw genome-wide methylation data were loaded 
in the R package minfi and assessed for basic quality control 
metrics, including determination of poorly performing probes 
with insignificant detection P values above background con-
trol probes (i.e., detection P value >0.01). Probes with a single 
nucleotide polymorphism in the single base extension site were 
excluded. X and Y chromosomes were removed from the raw 
methylation values. A total of 321,509 methylation loci were 
available for analysis. Batch (microarray chip) effect was cor-
rected for using the ComBat function in the R package SVA 
(surrogate variable analysis) and SWAN normalization was per-
formed to correct for intra-array differences between Illumina 
Type I and Type II probes. A total of 569 samples passed quality 
control metrics and were further considered for statistical anal-
yses. Methylation beta values (ranging from 0 to 1) representing 
the ratio of the intensity of the methylated allele to the sum of 
the intensities of the methylated and unmethylated alleles were 
used in analyses. The exposed (self-reported maternal smoking 
during pregnancy) were oversampled in the subset, and latter 
analysis with asthma status as the outcome in the subset with 
methylation data is weighted for the probability of selection in 
the subset conditional on exposure.
Outcomes and covariates
Children with asthma (cases) were defined as participants with 
a history of physiciandiagnosed asthma and the presence of 
two or more symptoms of coughing, wheezing, or shortness of 
breath in the 2 years preceding enrollment. Among the cases, 
asthma control was classified according to National Heart, 
Lung, and Blood Institute measures.30 Asthma control was clas-
sified as having controlled, partially controlled, or uncontrolled 
asthma. Asthma and asthma-related outcomes were all ascer-
tained at the time of recruitment in the study.
Pulmonary function results in the cases were obtained 
through spirometry using KoKo PFT Spirometers (nSpire 
Health Inc., Louisville, CO) according to American Thoracic 
Society criteria.31 Participants were asked not to use their bron-
chodilator medication 8 hours before spirometry testing. Up to 
eight tracings were obtained to collect five reproducible expira-
tory flow–volume curves with less than 5% variability in forced 
expiratory volume in one second (FEV1 in liters). For analysis, 
the loop with the best sum of FEV1 and forced vital capacity 
(FVC) was extracted. Information on age, sex, and height was 
recorded, while further demographic information, medical his-
tories, and environmental exposures were obtained through the 
questionnaires. Exposure to ambient particulate matter less than 
10 μm in diameter (PM10) was estimated based on self-reported 
residential histories from birth (geographic coordinates for each 
residence were using TomTom/Tele Atlas EZ-Locate software 
(TomTom, Amsterdam, The Netherlands)) and regional ambient 
air quality monitoring data acquired from the US Environmental 
Protection Agency Air Quality System. Exposure was estimated 
by calculating the inverse distance-squared weighted average 
from the four closest air quality monitoring stations within 50 
km of the residence for each year.
Covariates of interest in our analyses were, sex, age, eth-
nicity, recruitment region, health insurance, maternal educa-
tion, self-reported exposures to mold and pets in the household, 
and average PM10 exposure in the first 3 years of life. Analyses 
were conducted in 506 participants with complete covariate 
data.
Statistical Analyses
We assessed relationships between self-reported exposures and 
methylation values of 148 loci reported with false discovery 
rate (FDR)–adjusted P values <0.05 in a meta-analysis consist-
ing of eight different older child cohorts as reported in Joubert 
et al.18 Linear regression models were used to assess associa-
tions between self-reported maternal smoking and DNA meth-
ylation levels at specific CpG loci. We accounted for multiple 
comparisons by controlling the FDR at 5%. To account for the 
case-control design of the study, these models were weighted 
for the prevalence of the asthma in the target population and 
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proportion of asthma cases in our sample, to obtain consistent 
estimators for the parameters.32,33
We then examined loci with associations with self-reported ex-
posure with FDR-adjusted P values<0.05 in our own sample, as 
potential mediators of effects of in utero tobacco smoke exposure 
on asthma status, asthma control, as well as pulmonary function. 
Associations with asthma status were assessed with logistic re-
gression; logistic regression models restricted to the cases were 
used for asthma control as the outcome with “controlled” asthma 
as the referent category compared to “not well controlled” or 
“very poorly controlled” in a single collapsed category. Linear 
models restricted to the cases were used for lung function param-
eters, specifically FEV1, FVC, and the FEV1/FVC ratio.
Mediation analysis was performed for those CpG loci where 
95% confidence intervals (CI) for associations observed for 
the outcomes of interest did not include the null. For media-
tion analysis, we also considered additional loci on identified 
genes that were not on the original a priori list if CIs for the 
associations between methylation at the locus and the exposure 
and the outcome did not include the null. Loci that were in-
dividually associated with the exposure and outcome were si-
multaneously entered in a model for the outcome (adjusted for 
covariates and the exposure), and those that remained signifi-
cantly associated with the outcome were retained for mediation 
analysis. Total effects were partitioned to direct and indirect 
effects, estimated according to an extension of product method 
suitable for case–control data.33,34 Direct effects (not mediated 
through methylation) were estimated from the parameter for 
the exposure (self-reported maternal smoking) in models for 
the outcome, including both exposure and mediators (DNA 
methylation levels at identified loci) as predictors. Indirect 
effects (mediated through methylation) were estimated from the 
product of the parameters for the exposure from models for 
the mediators and the parameter from the mediators from the 
model for the outcome, with 95% CIs for direct and indirect 
effects estimated from 1,000 bootstrap samples.35 The direct 
effect here has the interpretation of the contrast in the outcome 
(e.g., asthma status) between the exposed (to maternal smoking) 
and the unexposed had the mediator(s) (DNA methylation) was 
at the levels of the unexposed in everyone. The indirect effect is 
the contrast in the outcome among the exposed in those where 
the mediators assume the levels under exposure and those where 
the mediators assume the levels under no exposure.34,36
The exposure of interest was entered in all models as an in-
dicator variable for self-reported maternal smoking during 
pregnancy. All models further included variables for age, sex, 
recruitment region, and ethnicity, a categorical variable for ma-
ternal education (elementary school or less, some high school, 
high school or equivalent, at least some college, college grad), 
indicator variable for whether or not the family had health in-
surance, average PM10 exposure in the child’s first three years of 
life, and indicators for parental self-reported exposures to mold 
and pets in the household; models for lung function also con-
trolled for height and height squared. Analyses for outcome and 
methylation associations were controlled for cell type heteroge-
neity using variables derived from ReFACTor,37 a method based 
on principal component analysis designed for cell type heteroge-
neity correction in epigenetics studies. Sensitivity analyses were 
performed excluding subjects identified as outliers in ReFACTor 
(n=13). Data on cell type heterogeneity data in this sample are 
also extensively detailed by Rahmani et al.37
This study was approved by the institutional review board 
at UC San Francisco. All subjects (or their parents) provided 
written informed consent.
Results
Demographic and asthma outcomes information in the study 
sample with DNA methylation data are summarized in Table 1. 
eTable S1, http://links.lww.com/EE/A44 compares these charac-
teristics between the study sample with DNA methylation data 
and the entire GALA II study.
Table 2 summarizes the top associations (i.e., FDR-adjusted P 
value ≤ 0.05 for the current study) out of the 148 loci tested for 
association with self-reported maternal smoking during preg-
nancy, sorted by FDR-adjusted P value. Observed distributions 
for DNA methylation levels for these loci are summarized in 
boxplots in eFigure S1, http://links.lww.com/EE/A41. Summary 
statistics on methylation levels are also given in eTable S2, 
http://links.lww.com/EE/A44. Overall, the range of methylation 
for each CpG locus was not very wide, with interquartile ranges 
varying from 3.9% to 14.2%.
Table 1
Demographic characteristics of study sample of 572 Latino 
children with methylation data from the GALA II asthma case 
control study.
Characteristic, n (%)
Cases  
(N=310)
Controls  
(N=262)
Male 156 (50.3) 130 (49.6)
Age, mean±SD 12.4 ± 3.4 12.7 ± 3.5
Maternal smoking during pregnancy 59 (19.0) 21 (8.0)
Maternal education*
  Less than high school 104 (33.9) 121 (46.5)
  High school grad. or equivalent 89 (29.0) 64 (24.6)
  At least some college 114 (37.1) 75 (28.8)
Family had health insurance 292 (94.2) 231 (88.1)
Mold exposure in the household 102 (32.9) 61 (23.3)
Pets in the household 114 (36.8) 104 (39.7)
Recruitment region
  Chicago 91 (29.4) 85 (32.4)
  Houston 21 (6.8) 28 (10.7)
  New York 21 (6.8) 31 (11.8)
  Puerto Rico 132 (42.6) 60 (22.9)
  SF Bay Area 45 (14.5) 58 (22.1)
Ethnicity
  Mexican 124 (40) 152 (58.0)
  Other Latino 40 (12.9) 37 (14.1)
  Puerto Rican 146 (47.1) 73 (27.9)
Asthma control
  Controlled 88 (28.4) .
  Partially controlled 106 (34.2) .
  Uncontrolled 116 (37.4) .
PM
10
 in first 3 years (μg/m3 mean±SD) 29.5 ± 5.7 29.2 ± 5.3
*Information on maternal education, insurance, and PM
10
 exposure was available in 567, 567, and 
517 subjects, respectively.
GALA II indicates Genes-environments and Admixture in Latino Americans; PM, particulate matter.
Table 2
Difference in methylation levels associated with self-reported 
maternal smoking for selected CpG loci, presented by 
increasing FDR adjusted P value.*
CpG locus (gene)†
Change  
(95% CI), P FDR-adjusted P
cg18132363 (LINC00473)† −4.1 (−6.0, −2.1), <0.0001 0.0049
cg26764244 (GNG12) −2.3 (−3.4, −0.2), <0.0001 0.0049
cg13822849 (OLFM1) 1.5 (0.6, 2.5), <0.001 0.0400
cg05575921 (AHRR) −1.5 (−2.4, −0.6), 0.002 0.0489
cg22549041 (CYP1A1) 3.6 (1.2, 5.9), 0.0019 0.0489
cg26889659 (EXOC2) −5.7 (−9.2, −2.1), 0.0020 0.0489
cg25189904 (GNG12) −2.6 (−4.3, −0.9), 0.0023 0.05
*Results from linear models with methylation as the outcome and adjusted for age, sex, ethnicity, 
recruitment region, maternal education, health insurance, PM
10
 exposure in the first 3 years of life, 
self-reported mold and pets in the household, and ReFACTor variables. Models weighted for the 
prevalence of the outcome and proportion of cases.
†The gene for CpG locus cg18132363 is the nearest (within 10 Mb) genes to the locus as opposed 
to a mapped gene.
CpG indicates cytosine-phosphate-guanine; FDR, false discovery rate.
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Associations between self-reported maternal smoking, as well 
as methylation at CpG loci and asthma status and asthma con-
trol are presented in Table 3. DNA methylation at CpG locus 
cg05575921 on the AHRR gene resulted in the strongest asso-
ciation with asthma status in magnitude, with a 1% increase in 
methylation levels corresponding to an odds ratio (OR) of 0.90 
(95% CI = 0.85, 0.96). Associations between the same locus and 
asthma control were in the same direction though weaker, and 
CIs included the null, with a 1% increase in methylation corre-
sponding to an OR of 0.97 (95% CI = 0.89, 1.06) for asthma 
control. No other loci considered yielded associations with odds 
of asthma where the 95% CIs did not include the null. Although 
asthma control was strongly associated with self-reported ma-
ternal smoking, CIs for the associations between this outcome 
and all the selected loci included the null.
The OR for the total effect of in utero tobacco smoke expo-
sures on asthma status using the full GALA II study sample with 
complete data on self-reported maternal smoking and covariates 
as listed above (n=3364) was 1.48 (95% CI = 1.03, 2.11). In 
analysis for the same association, in the subsample with DNA 
methylation data (using weights to account for the probability 
of selection into the sample with DNA methylation data given 
exposure), the effect estimate was nearly the same, but CIs were 
much wider and included the null (OR = 1.47; 95% CI = 0.60, 
3.59).
Results from mediation analysis considering CpG locus 
cg05575921 as a potential mediator of the effect of maternal 
smoking during pregnancy are summarized in Table  4. The 
corresponding direct effect of in utero tobacco smoke expo-
sures was an OR of 1.23 (95% CI = 0.48, 3.16) with an indi-
rect effect mediated through DNA methylation at AHRR locus 
cg05575921 of 1.18 (95% CI = 1.07, 1.68).
There was a 0.03 decrease (95% CI = –0.05, –0.01) in the 
FEV1/FVC ratio among the cases associated with self-reported 
maternal smoking, but 95% CI for individual associations with 
FEV1 and FVC included the null. Observed associations be-
tween lung function parameters and DNA methylation at the 
CpG loci considered were small in magnitude, and generally 
95% CIs included the null for both FEV1 and FVC (eFigures S2 
and S3; http://links.lww.com/EE/A42 and http://links.lww.com/
EE/A43).
Discussion
We examined the relationship between DNA methylation at 
loci previously associated with in utero tobacco smoke expo-
sures and asthma-related outcomes in a sample of Latino chil-
dren from the mainland United States and Puerto Rico. We 
observed associations between DNA methylation levels at the 
cg05575921 CpG locus on the AHRR gene and asthma status. 
Overall, the observed findings support DNA methylation as a 
potential biologic pathway of the effects of in utero tobacco 
smoke exposure on asthma status, while evidence for potential 
effects of DNA methylation at loci considered in this study on 
asthma control and lung function parameters (FEV1, FVC, and 
the FEV1/FVC ratio) among children with asthma was weaker 
and 95% CIs always included the null.
Tobacco smoke exposures have been shown to adversely affect 
lung growth in children, including effects of in utero exposures 
independent of subsequent postnatal SHS exposures.9,11 This 
suggests potential damage may begin during critical periods 
of fetal development and is in accordance with the hypothesis 
that risk of chronic disease begins in utero. Tobacco smoke rep-
resents a mixture of chemicals, such as nicotine, carbon mon-
oxide, and polycyclic aromatic hydrocarbons, which are known 
to have harmful effects. Nicotine has been linked with differen-
tiation of developing lung cells into abnormal phenotypes38 and 
has been shown to cross the placenta in utero.14,39
Epigenetic regulation as a potential mechanism of disease is 
an area of particular interest in recent asthma literature40 and 
also has been strongly linked with in utero tobacco smoke expo-
sures. Gene expression can be modulated by epigenetic modifi-
cations, including methylation of CpG islands in specific genes, 
thus affecting fetal development and contributing to chronic di-
sease. Epigenetic modifications in relation to in utero tobacco 
smoke exposures have been reported in newborns and placental 
and cord blood samples18,22 but also later in childhood18 and 
adulthood,20 indicating potentially persistent changes in the 
epigenome associated with these exposures. The harmful effects 
of in utero tobacco smoke exposures are also documented 
throughout the life course, with potential damage beginning 
during fetal development, resulting in attenuated lung function 
and increased risk of childhood asthma9,41 early in life but also 
persisting effects later in childhood16,42 and potentially adult-
hood.15 DNA methylation can potentially be intervened upon 
to reduce effects of harmful exposures mediated through these 
mechanisms as suggested by a recent study, indicating restora-
tion of DNA methylation in pregnant smokers through Vitamin 
C treatment.28,29 Dietary interventions have also been shown to 
potentially ameliorate health effects of air pollution exposures 
mediated through DNA methylation.43 This could prove to be 
a useful mechanism to supplement interventions targeting a re-
duction in the prevalence of exposure, if interventions on the 
mediator can help reduce exposure effects after the exposure 
has already taken place (i.e., potential dietary supplementation 
in children born to mothers who smoked).
Our results are consistent with the hypothesis that DNA 
methylation is a potential biologic mediator of the harmful 
effects of in utero tobacco smoke exposures on asthma and asth-
ma-related outcomes, particularly with respect to methylation 
at the AHRR gene. Differential methylation at AHRR loci has 
been reported in other studies of maternal smoking18,19 where 
exposure results in reduced methylation. The aryl hydrocarbon 
receptor has a role in detoxification and immune system regu-
lation44 and has been linked with inflammation in the lung.45 
Epigenetic changes in AHRR have been shown to persist during 
childhood.14,46 Epigenetic changes at the AHRR gene have also 
been observed in studies of adolescent smokers.47 In our study, 
self-reported maternal smoking was associated with lower 
methylation at an AHRR CpG locus (cg05575921). This locus 
has consistently been reported to be differentially methylated 
in association to smoking exposures, including in studies using 
Table 3
Odds ratios (95% CIs) for asthma status and asthma control 
associated with a 1% methylation increase at selected loci and 
self-reported maternal smoking during pregnancy.
CpG locus  
(associated gene)*
OR (95% CI)
Asthma  
status† (n=506)
Asthma  
control† (n=289)
Maternal smoking 1.47 (0.60, 3.59)‡ 2.03 (0.88, 4.72)
cg18132363 (LINC00473)* 1.02 (0.98, 1.05) 0.98 (0.92, 1.03)
cg26764244 (GNG12) 1.03 (0.97, 1.09) 0.97 (0.90, 1.05)
cg13822849 (OLFM1) 1.06 (0.98, 1.13) 0.90 (0.82, 1.00)
cg05575921 (AHRR) 0.90 (0.83, 0.96) 0.96 (0.87, 1.05)
cg22549041 (CYP1A1) 0.99 (0.97, 1.02) 0.99 (0.97, 1.01)
cg26889659 (EXOC2) 1.01 (0.99, 1.03) 1.01 (0.98, 1.04)
cg25189904 (GNG12) 1.00 (0.96, 1.04) 1.01 (0.95, 1.07)
*The gene for CpG locus cg18132363 is the nearest (within 10 Mb) gene to the locus as opposed 
to a mapped gene.
†Results for asthma status are from logistic models for all subjects with DNA methylation and 
covariate data, while results for asthma control are from logistic models restricted to the cases. All 
models adjusted for age, sex, ethnicity, recruitment region, maternal education, health insurance, 
PM
10
 exposure in the first 3 years of life, self-reported mold and pets in the household, and 
ReFACTor variables.
‡The OR corresponding to self-reported maternal smoking is weighted by the probability of 
selection from the original GALA II study as the exposed were oversampled for the subset in the 
current study.
CI indicates confidence interval; CpG, cytosine-phosphate-guanine; GALA II, Genes-environments 
and Admixture in Latino Americans; OR, odds ratio.
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maternal plasma cotinine, a sensitive tobacco smoke exposure 
biomarker, to assess exposure.18,19,21,47,48 In turn, an increase in 
methylation at this locus was associated with decreased risk of 
asthma. In our study population, the same directions of associ-
ations (though weaker in magnitude and with 95 CIs including 
the null) were observed for asthma control, FEV1, and FEV1/
FVC among children and adolescents with asthma. Results for 
asthma control and lung function parameters were limited to 
the asthma cases and therefore were less powered.
Of the loci considered, differential methylation associated with 
self-reported maternal smoking at the AHRR cg05575921 locus 
was the only locus consistently associated with harmful effects 
in all outcomes considered, though CIs often included the null. 
AHRR loci, however, were not found among the top loci associ-
ated with childhood asthma in an epigenome-wide meta-analysis 
of DNA methylation and childhood asthma.49 Our approach had 
exposure-mediator associations as the starting point, whereas 
analyses of epigenome-wide associations jointly for exposures 
and outcomes of interest could be a future direction.
Results from mediation analysis are subject to several assump-
tions, so interpretation of these findings should be made in light 
of these assumptions as well as other limitations of observa-
tional data. In addition to the assumptions of no unmeasured 
exposure-outcome confounders required for analyses of total 
effects, assumptions of no unmeasured exposure-mediator, or 
mediator-outcome confounders and no mediator-outcome con-
founders affected by the exposure are also required. Our results 
are also estimated under the assumption of no exposure-me-
diator interactions. The assumption of no mediator-outcome 
confounding will likely be particularly problematic in studies 
examining DNA methylation as a potential mediator, as factors 
such as maternal diet and genetics could all act as mediator-out-
come confounders. DNA methylation at other loci could also be 
a confounder even if unassociated with exposure and could be 
an issue given the loci reported to be associated with the out-
come as highlighted by Reese et al.49 Failure of this assumption 
may have resulted in overestimation of indirect effects in our 
case.
A further point of caution in mediation analysis is bias due 
to potential exposure misclassification. While nondifferential 
misclassification of exposure is generally expected to lead to 
bias toward the null with respect to total effects, bias in indirect 
effects can be in either direction.34 Mother’s reported smoking 
during pregnancy is subject to misclassification but is generally 
considered a valid measure of fetal tobacco smoke exposure.50 
In our study, self-reported exposures are consistent with pre-
vious reports and national estimates by race/ethnicity,11,51 so 
misclassification of exposure is not expected to be a major issue. 
The exposure–mediator associations seen in our study were 
also observed in studies that used cotinine to assess exposure. 
Methylation differences between the exposed and unexposed 
based on self-reported measures in our study were in the same 
direction for 25 out of 26 CpG loci reported in a study using 
mid-pregnancy maternal cotinine to determine in utero tobacco 
smoke exposures.52 This lends further confidence to our self-re-
ported measure of exposure.
The cross-sectional nature of the data is a limitation of the 
study. Blood samples were collected at one point in time, con-
current with outcome assessment, which was retrospective with 
respect to ascertainment of asthma status and asthma-related 
outcomes. The temporal relationship between DNA methyla-
tion and asthma outcomes cannot therefore be established with 
certainty in this dataset. In this regard, DNA methylation meas-
ured in cord blood would be more advantageous; however, evi-
dence in the literature supports effects of in utero exposures on 
DNA methylation, observed early in life and prior to manifesta-
tion of chronic disease and other clinical outcomes, and there-
fore can be considered as potential intermediates. Furthermore, 
DNA methylation associations from prenatal exposures such 
as parental smoke exposure could persist later in life,20,53 and 
DNA methylation measured in child blood may still be a useful 
marker for mediators.
Among the strengths of the study was the ability to adjust for 
potential confounders and co-exposures such as socioeconomic 
status variables and other co-exposures. Our study is also based 
on a sample of Latino children from the GALA II study, the 
largest gene-environment study of pediatric asthma in Latinos 
in the United States. Some minority children, particularly Puerto 
Ricans, are both more at risk for asthma-related morbidity and 
mortality25 and have higher prevalence of maternal smoking 
during pregnancy compared to the rate for the entire US pop-
ulation. Our target population, therefore, is of particular clin-
ical and public health interest given the potential differences in 
susceptibility to the outcome in light of the greater burden of 
exposure. In addition, a previous study in this population in-
dicated that methylation at loci associated with environmental 
exposures including maternal smoking was also associated with 
ethnicity and genetic ancestry.54 This finding in addition to the 
differential prevalence of exposure and outcome by race/eth-
nicity introduces the potential for lack of transportability of 
effects from one population to another, and it is therefore im-
portant to assess these associations in populations of different 
racial/ethnic backgrounds. Finally, and to our knowledge, the 
current study is the first to apply mediation analysis of in utero 
tobacco smoke exposure effects on asthma, mediated through 
epigenetic modification of DNA methylation. DNA methylation 
as a potential mediator of effects is an area of increasing interest 
in asthma epidemiology and one which may provide insights as 
to the biochemical mechanisms through which external expo-
sures exert their effects.40
In summary, we observed associations between DNA methyl-
ation at loci previously linked to in utero tobacco smoke expo-
sure and asthma-related outcomes. Our findings are consistent 
with DNA methylation acting as a mediator of potential effects 
of in utero tobacco smoke exposures on asthma status. Potential 
future studies including mediation analysis in longitudinal pro-
spective studies where exposure, mediators, and outcomes are 
assessed in a temporal order as hypothesized will benefit our 
Table 4
Associations between DNA methylation at selected AHRR loci 
(mediators) and self-reported maternal smoking (exposure) from 
a model for the mediator, as well as associations between DNA 
methylation and asthma status (outcome) from a model for the 
outcome.
Change in DNA  
methylation (SE)
Direct and  
Indirect Effects
Mediator model*   
  AHRR locus cg05575921 −0.015 (0.005)  
Outcome model† Change in log(odds) of asthma (SE) OR (95% CI)‡
  Maternal smoking 0.21 (0.48) DE: 1.23 (0.48, 3.16)
  AHRR locus cg05575921 −11.01 (3.47) IE: 1.18 (1.07, 1.68)
Model parameters from both models are used to estimate indirect (mediated) effects of exposure 
(results based on the GALA II subsample with DNA methylation and complete covariate data 
(n=506)).
CI indicates confidence interval; DE, direct effect; GALA II, Genes-Environments and Admixture in 
Latino Americans; IE, indirect effect; OR, odds ratio.
*Model for the mediator and adjusted for age, sex, ethnicity, recruitment region, maternal 
education, health insurance, PM
10
 exposure in the first 3 years of life, self-reported mold and pets 
in the household, and ReFACTor variables. Models weighted for the prevalence of the outcome and 
proportion of cases. Standard errors estimated based on bootsraps.
†Model for the outcome was a logistic model including the exposure and mediators and adjusted 
for age, sex, ethnicity, recruitment region, maternal education, health insurance, PM
10
 exposure in 
the first 3 years of life, self-reported mold and pets in the household, and ReFACTor variables and 
weighted for the probability of selection in the subsample.
‡The log(odds) of the direct effect is equivalent model parameter for the exposure in the outcome 
model. The log(odds) for the indirect effect are the product between the model parameter for the 
CpG locus in the outcome model times the model parameter for the exposure in the respective 
mediator model, that is, the OR for IE: exp((−0.015)×(−11.01)). 95% CIs estimated based on 
bootstraps.
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overall understanding of in utero tobacco smoke exposure, as 
will studies with gene expression as an additional part of the 
pathway of mediated mechanisms of disease.
Conflicts of interest statement
The authors declare that they have no conflicts of interest with 
regard to the content of this report.
References
1. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in 
utero, blood pressure in childhood and adult life, and mortality from 
cardiovascular disease. BMJ. 1989;298:564–567.
2. Waterland RA, Michels KB. Epigenetic epidemiology of the develop-
mental origins hypothesis. Annu Rev Nutr. 2007;27:363–388.
3. Stocks J, Hislop A, Sonnappa S. Early lung development: lifelong effect 
on respiratory health and disease. Lancet Respir Med. 2013;1:728–742.
4. U.S. Department of Health and Human Services. The Health 
Consequences of Smoking: 50 Years of Progress. A Report of the 
Surgeon General. Atlanta, GA: US Department of Health and Human 
Services, Centers for Disease Control and Prevention, National Center 
for Chronic Disease Prevention and Health Promotion, Office on 
Smoking and Health; 2014.
5. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal envi-
ronmental tobacco smoke exposure and children’s health. Pediatrics. 
2004;113(4 Suppl):1007–1015.
6. Best D. Secondhand and prenatal tobacco smoke exposure. Pediatrics. 
2009;124:e1017–e1044.
7. U.S. Department of Health and Human Services. The Health 
Consequences of Involuntary Exposure to Tobacco Smoke: A Report of 
the Surgeon General. Atlanta, GA: US Department of Health and Human 
Services, Centers for Disease Control and Prevention, Coordinating 
Center for Health Promotion, National Center for Chronic Disease 
Prevention and Health Promotion, Office on Smoking and Health; 2006.
8. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouëf PN. Effects of maternal 
smoking during pregnancy and a family history of asthma on respira-
tory function in newborn infants. Lancet. 1996;348:1060–1064.
9. Gilliland FD, Li YF, Peters JM. Effects of maternal smoking during preg-
nancy and environmental tobacco smoke on asthma and wheezing in 
children. Am J Respir Crit Care Med. 2001;163:429–436.
10. Hu FB, Persky V, Flay BR, Zelli A, Cooksey J, Richardson J. Prevalence 
of asthma and wheezing in public schoolchildren: association with 
maternal smoking during pregnancy. Ann Allergy Asthma Immunol. 
1997;79:80–84.
11. Oh SS, Tcheurekdjian H, Roth LA, et al. Effect of secondhand smoke 
on asthma control among black and Latino children. J Allergy Clin 
Immunol. 2012;129:1478.e7–1483.e7.
12. Wongtrakool C, Roser-Page S, Rivera HN, Roman J. Nicotine alters lung 
branching morphogenesis through the alpha7 nicotinic acetylcholine re-
ceptor. Am J Physiol Lung Cell Mol Physiol. 2007;293:L611–L618.
13. Wu ZX, Hunter DD, Kish VL, Benders KM, Batchelor TP, Dey RD. 
Prenatal and early, but not late, postnatal exposure of mice to side-
stream tobacco smoke increases airway hyperresponsiveness later in life. 
Environ Health Perspect. 2009;117:1434–1440.
14. Gibbs K, Collaco JM, McGrath-Morrow SA. Impact of to-
bacco smoke and nicotine exposure on lung development. Chest. 
2016;149:552–561.
15. Upton MN, Watt GC, Davey Smith G, McConnachie A, Hart CL. 
Permanent effects of maternal smoking on offsprings’ lung function. 
Lancet. 1998;352:453.
16. Gilliland FD, Berhane K, McConnell R, et al. Maternal smoking during 
pregnancy, environmental tobacco smoke exposure and childhood lung 
function. Thorax. 2000;55:271–276.
17. Gilliland FD, Berhane K, Li YF, Rappaport EB, Peters JM. Effects of 
early onset asthma and in utero exposure to maternal smoking on child-
hood lung function. Am J Respir Crit Care Med. 2003;167:917–924.
18. Joubert BR, Felix JF, Yousefi P, et al. DNA methylation in newborns and 
maternal smoking in pregnancy: genome-wide consortium meta-analy-
sis. Am J Hum Genet. 2016;98:680–696.
19. Reese SE, Zhao S, Wu MC, et al. DNA methylation score as a biomarker 
in newborns for sustained maternal smoking during pregnancy. Environ 
Health Perspect. 2017;125:760–766.
20. Richmond RC, Suderman M, Langdon R, Relton CL, Davey Smith G. 
DNA methylation as a marker for prenatal smoke exposure in adults. 
Int J Epidemiol. 2018;47:1120–1130.
21. Küpers LK, Xu X, Jankipersadsing SA, et al. DNA methylation mediates 
the effect of maternal smoking during pregnancy on birthweight of the 
offspring. Int J Epidemiol. 2015;44:1224–1237.
22. Morales E, Vilahur N, Salas LA, et al. Genome-wide DNA methylation 
study in human placenta identifies novel loci associated with maternal 
smoking during pregnancy. Int J Epidemiol. 2016;45:1644–1655.
23. Chhabra D, Sharma S, Kho AT, et al. Fetal lung and placental meth-
ylation is associated with in utero nicotine exposure. Epigenetics. 
2014;9:1473–1484.
24. Tong VT, Dietz PM, Morrow B, et al; Centers for Disease Control and 
Prevention (CDC). Trends in smoking before, during, and after pregnan-
cy–pregnancy risk assessment monitoring system, United States, 40 sites, 
2000-2010. MMWR Surveill Summ. 2013;62:1–19.
25. Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, 
health care use, and mortality in the United States, 2001–2010. 2012:1–8.
26. Lara M, Akinbami L, Flores G, Morgenstern H. Heterogeneity of child-
hood asthma among Hispanic children: puerto rican children bear a dis-
proportionate burden. Pediatrics. 2006;117:43–53.
27. Zhang B, Hong X, Ji H, et al. Maternal smoking during pregnancy and 
cord blood DNA methylation: new insight on sex differences and effect 
modification by maternal folate levels. Epigenetics. 2018;13:505–518.
28. Shorey-Kendrick LE, McEvoy CT, Ferguson B, et al. Vitamin C prevents 
offspring DNA methylation changes associated with maternal smoking 
in pregnancy. Am J Respir Crit Care Med. 2017;196:745–755.
29. Sharma S. The epigenetics of intrauterine smoke exposure: can maternal 
vitamin C supplementation prevent neonatal respiratory disease? Am J 
Respir Crit Care Med. 2017;196:672–674.
30. U.S. Department of Health and Human Services. EPR-3. Expert Panel 
Report 3: Guidelines for the Diagnosis and Management of Asthma: Full 
Report 2007. Bethesda, MD; U.S. Department of Health and Human 
Services; National Institutes of Health; National Heart, Lung, and Blood 
Institute; National Asthma Education and Prevention Program; 2007.
31. American Thoracic Society. Standardization of spirometry, 1994 
update. American Thoracic Society. Am J Respir Crit Care Med. 
1995;152:1107–1136.
32. van der Laan MJ. Estimation based on case-control designs with known 
prevalence probability. Int J Biostat. 2008;4:Article 17.
33. Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for 
a dichotomous outcome. Am J Epidemiol. 2010;172:1339–1348.
34. Vanderweele TJ. Explanation in Causal Inference: Methods of Mediation 
and Interaction. New York, NY: Oxford University Press; 2015.
35. VanderWeele TJ, Vansteelandt S. Mediation analysis with multiple medi-
ators. Epidemiol Methods. 2014;2:95–115.
36. Richiardi L, Bellocco R, Zugna D. Mediation analysis in epidemiology: 
methods, interpretation and bias. Int J Epidemiol. 2013;42:1511–1519.
37. Rahmani E, Zaitlen N, Baran Y, et al. Sparse PCA corrects for cell type 
heterogeneity in epigenome-wide association studies. Nat Methods. 
2016;13:443–445.
38. Rehan VK, Asotra K, Torday JS. The effects of smoking on the devel-
oping lung: insights from a biologic model for lung development, home-
ostasis, and repair. Lung. 2009;187:281–289.
39. Jauniaux E, Gulbis B, Acharya G, Thiry P, Rodeck C. Maternal tobacco 
exposure and cotinine levels in fetal fluids in the first half of pregnancy. 
Obstet Gynecol. 1999;93:25–29.
40. Harb H, Renz H. Update on epigenetics in allergic disease. J Allergy Clin 
Immunol. 2015;135:15–24.
41. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy, fetal develop-
ment, and childhood asthma. Am J Public Health. 2004;94:136–140.
42. Cunningham J, Dockery DW, Speizer FE. Maternal smoking during 
pregnancy as a predictor of lung function in children. Am J Epidemiol. 
1994;139:1139–1152.
43. Zhong J, Colicino E, Lin X, et al. Cardiac autonomic dysfunction: par-
ticulate air pollution effects are modulated by epigenetic immunoregu-
lation of Toll-like receptor 2 and dietary flavonoid intake. J Am Heart 
Assoc. 2015;4:e001423.
44. Hanieh H. Toward understanding the role of aryl hydrocarbon receptor 
in the immune system: current progress and future trends. Biomed Res 
Int. 2014;2014:520763.
45. Beamer CA, Shepherd DM. Role of the aryl hydrocarbon receptor (AhR) 
in lung inflammation. Semin Immunopathol. 2013;35:693–704.
46. Richmond RC, Simpkin AJ, Woodward G, et al. Prenatal exposure to 
maternal smoking and offspring DNA methylation across the lifecourse: 
findings from the Avon Longitudinal Study of Parents and Children 
(ALSPAC). Hum Mol Genet. 2015;24:2201–2217.
47. Beach SRH, Lei MK, Ong ML, Brody GH, Dogan MV, Philibert RA. 
MTHFR methylation moderates the impact of smoking on DNA 
Neophytou et al. • Environmental Epidemiology (2019) 3:e048 www.environmentalepidemiology.com
7
methylation at AHRR for African American young adults. Am J Med 
Genet B Neuropsychiatr Genet. 2017;174:608–618.
48. Zeilinger S, Kühnel B, Klopp N, et al. Tobacco smoking leads to ex-
tensive genome-wide changes in DNA methylation. PLoS One. 
2013;8:e63812.
49. Reese SE, Xu CJ, den Dekker HT, et al. Epigenome-wide meta-analysis 
of DNA methylation and childhood asthma. J Allergy Clin Immunol. 
2018. [Epub ahead of print].
50. Pickett KE, Rathouz PJ, Kasza K, Wakschlag LS, Wright R. Self-reported 
smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr 
Perinat Epidemiol. 2005;19:368–376.
51. Perreira KM, Cortes KE. Race/ethnicity and nativity differences in 
alcohol and tobacco use during pregnancy. Am J Public Health. 
2006;96:1629–1636.
52. Joubert BR, Håberg SE, Nilsen RM, et al. 450K epigenome-wide scan iden-
tifies differential DNA methylation in newborns related to maternal smok-
ing during pregnancy. Environ Health Perspect. 2012;120:1425–1431.
53. Cardenas A, Rifas-Shiman SL, Agha G, et al. Persistent DNA methyla-
tion changes associated with prenatal mercury exposure and cognitive 
performance during childhood. Sci Rep. 2017;7:288.
54. Galanter JM, Gignoux CR, Oh SS, et al. Differential methylation be-
tween ethnic sub-groups reflects the effect of genetic ancestry and envi-
ronmental exposures. Elife. 2017;6:e20532.
